首页> 外文期刊>Liver international : >The AST/ALT ratio as an indicator of cirrhosis in patients with PBC.
【24h】

The AST/ALT ratio as an indicator of cirrhosis in patients with PBC.

机译:AST / ALT比可作为PBC患者肝硬化的指标。

获取原文
获取原文并翻译 | 示例
           

摘要

A non-invasive, simple and non-expensive test to predict cirrhosis would be highly desirable. The aspartate aminotransferase/alanine aminotransferase (AST/ALT) ratio has been proven to be such an indicator of cirrhosis in alcoholic liver disease, hepatitis C. To test whether the AST/ALT ratio is a marker of cirrhosis also in patients with primary biliary cirrhosis (PBC). The study consisted of 160 patients. In 126 patients, we had clinical and laboratory data at the time of diagnosis and follow-up with outcome: liver-related death, liver transplantation and survival. In 121 patients, we had laboratory data and liver histology. We found that the AST/ALT ratio was significantly higher in cirrhotic patients than in non-cirrhotic patients. A high AST/ALT ratio was significantly associated with esophageal varices and ascites. In a multivariate analysis, bilirubin and ALP were predictors of poor prognosis. The AST/ALT ratio seems to be of clinical value as a hint to the diagnosis of cirrhosis in patients with PBC but not as a prognostic factor.
机译:非常需要一种非侵入性,简单且非昂贵的测试来预测肝硬化。天冬氨酸氨基转移酶/丙氨酸氨基转移酶(AST / ALT)的比例已被证明是酒精性肝病丙型肝炎的肝硬化指标。为了测试AST / ALT比率是否也是原发性胆汁性肝硬化患者的肝硬化指标(PBC)。该研究包括160名患者。在126例患者中,我们在诊断和随访时获得了临床和实验室数据,其结果包括:与肝有关的死亡,肝移植和生存。在121例患者中,我们具有实验室数据和肝脏组织学。我们发现,肝硬化患者的AST / ALT比明显高于非肝硬化患者。高AST / ALT比值与食管静脉曲张和腹水显着相关。在多变量分析中,胆红素和ALP是预后不良的预测指标。 AST / ALT比似乎具有临床价值,可作为诊断PBC患者肝硬化的提示,而不是预后因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号